A1 Journal article – refereed
Cytotoxicity study of ordered mesoporous silica MCM-41 and SBA-15 microparticles on Caco-2 cells




List of Authors: Heikkilä T, Santos H, Kumar N, Murzin D Yu, Salonen J, Laaksonen T, Peltonen L, Hirvonen J, Lehto V-P
Publisher: ELSEVIER SCIENCE BV
Publication year: 2010
Journal: European Journal of Pharmaceutics and Biopharmaceutics
Journal name in source: EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Journal acronym: EUR J PHARM BIOPHARM
Number in series: 3
Volume number: 74
Issue number: 3
Number of pages: 12
ISSN: 0939-6411

Abstract
Cytotoxicity of ordered mesoporous silica MCM-41 and SBA-15 microparticles (fractions between 1 and 160 mu m) was determined in vino on undifferentiated human colon carcinoma (Caco-2) cell line, considering the feasibility of using these silica-based materials in oral drug formulations The cellular endpoints employed for assessing the effects of the MCM-41 and SBA-15 microparticles on Caco-2 were (1) cell membrane integrity by monitoring live-cell protease activity (AFC) and by employing the flow cytometry method, (2) metabolic activity by monitoring total ATP content via luminescence assay, (3) activity of apoptotic effectors by caspase-3/7 activity assay The generation of reactive oxygen species (ROS) was also followed, specifically the hydrogen peroxide (H2O2) and the superoxide radical (O-2(-)) MCM-41 and SBA-15 microparticles caused cytotoxic effects on the Caco-2 cells, at most tested concentrations (O-2(-) 14 mg/ml) and incubation times (3 and 24 h) The effects on the cells included weakened cell membrane integrity, diminished cell metabolism and increased apoptotic signalling The loot cause for the cytotoxicity was heightened production of reactive oxygen species (ROS), especially the formation of the superoxide radical O-2(-) already after 3 h incubation with threshold close 1 mg/ml, apparently overwhelming the antioxidant defences and causing mitochondrial dysfunction. hence increasing the apoptotic signalling (c) 2009 Elsevier B.V All rights reserved

Last updated on 2019-21-08 at 22:01